Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Dec 22, 2022--
Dec. 22, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023.
Quantum-Si’s management will present on Thursday, January 12 at 10:30 am Pacific Standard Time. The discussions will cover recent company developments, including the recently-announced commercial availability of Quantum-Si’s groundbreaking Platinum™ instrument, which is the first system to enable next-generation, single-molecule protein sequencing.
A live and archived webcast of the events will be available in the Investors section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221222005515/en/
CONTACT: Investor Contact
KEYWORD: CALIFORNIA CONNECTICUT UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY TECHNOLOGY HEALTH GENERAL HEALTH PHARMACEUTICAL SEMICONDUCTOR HEALTH TECHNOLOGY OTHER SCIENCE RESEARCH GENETICS SCIENCE
SOURCE: Quantum-Si Incorporated
Copyright Business Wire 2022.
PUB: 12/22/2022 04:05 PM/DISC: 12/22/2022 04:06 PM